Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

KYTXKYTX
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in KYVERNA THERAPEUTICS INC

GOLDMAN SACHS GROUP INC holds 335,230 shares of KYTX (KYVERNA THERAPEUTICS INC), worth $3M as of 2026-Q2. The position was increased (+57.5% shares). KYTX represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$3M

Current Shares

335,230

Total Value Change

+$2.6M

Total Shares Change

+221,756

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
335,230
+57.5%
$3M0.0%$8.91
38
2026-Q1
Increased
212,910
+59.5%
$1.8M0.0%$8.02
37
2025-Q4
Increased
133,530
+209.6%
$1.3M0.0%$9.35
41
2025-Q3
Decreased
43,132
-68.4%
$258,7920.0%$5.94
0
2025-Q2
Increased
136,378
+30.6%
$418,6800.0%$3.28
30
2025-Q1
Decreased
104,460
-7.9%
$201,6080.0%$2.00
0
2024-Q4
New
113,474
-
$424,3930.0%$3.64
33

Other major holders of KYTX: RTW INVESTMENTS, LP, JENNISON ASSOCIATES LLC, BlackRock, Inc., PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used